Sutro Biopharma, Inc. - Common Stock, $0.001 par value per share (STRO)

CUSIP: 869367102

Q3 2020 13F Holders as of 30 Sep 2020

Holder snapshot 6 signals
Share change
+6,548,303
SEC-reported price per share
$10.05
Number of holders
87
Value change
+$67,545,691
Number of buys
57
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
16,607,375

Security key

869367102

Report period

Q3 2020

Institutions

87

Top holders

10

Ownership snapshot

Top reported holders of STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F Highest disclosed value: $18,379,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL has the largest disclosed position value at $18.38M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.
Disclosed position value Top 5
BVF INC/IL $18.38M
EVENTIDE ASSET MANAGEMENT, LLC $15.41M
RA CAPITAL MANAGEMENT, L.P. $14.9M
EcoR1 Capital, LLC $14.19M
SV Health Investors, LLC $14.16M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BVF INC/IL
13F
Company
13F
—
denominator unverified
$18,379,000
2,368,392 shares
— 30 Jun 2020
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$15,411,000
1,985,975 shares
— 30 Jun 2020
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$14,896,000
1,919,644 shares
— 30 Jun 2020
EcoR1 Capital, LLC
13F
Company
13F
—
denominator unverified
$14,189,000
1,828,492 shares
— 30 Jun 2020
SV Health Investors, LLC
13F
Company
13F
—
denominator unverified
$14,158,000
1,824,542 shares
— 30 Jun 2020
Samsara BioCapital, LLC
13F
Company
13F
—
denominator unverified
$13,002,000
1,675,579 shares
— 30 Jun 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
87
Shares
31,151,440
Rows available
87
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2026 Across Filers

Q2 2026 holders
3
Q3 2020 holders
87
Holder diff
84
Investor Q2 2026 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2026 value Q3 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .